Investigating the link between frailty and inflammation in hip fracture patients
Frailty in Hip Fracture Patients Treated With Surgery; the Role of Simple Inflammatory Biomarkers. An Observational Study
This study is looking to see if older adults with hip fractures who are more frail have higher levels of inflammation in their bodies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | University of Thessaly Academic / other |
| Locations | 2 sites (Larissa, Thessaly and 1 other locations) |
| Trial ID | NCT06614478 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the relationship between frailty and inflammatory biomarkers in elderly patients who have suffered hip fractures. It focuses on understanding whether patients with frailty exhibit a higher inflammatory burden as indicated by simple inflammatory biomarkers. The study will include patients aged over 65 years who are able to communicate and are not institutionalized. By analyzing these biomarkers, researchers hope to gain insights into the prognosis of frail hip fracture patients.
Who should consider this trial
Good fit: Ideal candidates for this study are elderly individuals over 65 years old who have suffered a hip fracture and are able to communicate.
Not a fit: Patients with severe cognitive dysfunction, those treated conservatively, or those with pathological fractures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prognostic assessments and tailored interventions for frail elderly patients with hip fractures.
How similar studies have performed: While the specific approach of this study may be novel, previous studies have indicated a correlation between frailty and inflammatory markers in similar populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age \>65 years, ASA PS I-III, non- institutionalized, able to communicate patients Exclusion Criteria: * Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate
Where this trial is running
Larissa, Thessaly and 1 other locations
- Larissa University Hospital — Larissa, Thessaly, Greece (Recruiting)
- Uhl — Larissa, Thessaly, Greece (Recruiting)
Study contacts
- Study coordinator: Eleni Arnaoutoglou, Professor
- Email: earnaout@gmail.com
- Phone: +302413502952
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.